Point of Care Diagnostics Market

Point of Care Diagnostics Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

146

Base Year:

2022

Aug - 2022

Format:

Report Code:

VMR-1821

Segments Covered

By Product Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology
By End Users Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratories
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 45.06 Billion
Revenue 2030:	USD 95.89 Billion
Revenue CAGR (2023 - 2030):	9.90%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Global Point of Care Diagnostics Market, 2016 - 2028 (USD Million)
3. Global Point of Care Diagnostics Market - by Product
  1. By Glucose Testing
  2. By Hb1Ac Testing
  3. By Coagulation Testing
  4. By Fertility/Pregnancy
  5. By Infectious Disease
  6. By Cardiac Markers
  7. By Thyroid Stimulating Hormone
  8. By Hematology
  9. By Primary Care Systems
  10. By Decentralized Clinical Chemistry
  11. By Feces
  12. By Lipid Testing
  13. By Cancer Marker
  14. By Blood Gas/Electrolytes
  15. By Ambulatory Chemistry
  16. By Drug of Abuse (DOA) Testing
  17. By Urinalysis/Nephrology
4. Global Point of Care Diagnostics Market - by End Users
  1. By Clinics
  2. By Hospitals
  3. By Home
  4. By Assisted Living Healthcare Facilities
  5. By Laboratories
5. Global Point of Care Diagnostics Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
6. Market comparative analysis
North America Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. North America Point of Care Diagnostics Market, 2016 - 2028 (USD Million)
3. North America Point of Care Diagnostics Market, by Product
  1. By Glucose Testing
  2. By Hb1Ac Testing
  3. By Coagulation Testing
  4. By Fertility/Pregnancy
  5. By Infectious Disease
  6. By Cardiac Markers
  7. By Thyroid Stimulating Hormone
  8. By Hematology
  9. By Primary Care Systems
  10. By Decentralized Clinical Chemistry
  11. By Feces
  12. By Lipid Testing
  13. By Cancer Marker
  14. By Blood Gas/Electrolytes
  15. By Ambulatory Chemistry
  16. By Drug of Abuse (DOA) Testing
  17. By Urinalysis/Nephrology
4. North America Point of Care Diagnostics Market, by End Users
  1. By Clinics
  2. By Hospitals
  3. By Home
  4. By Assisted Living Healthcare Facilities
  5. By Laboratories
5. North America Point of Care Diagnostics Market, by Country
  1. U.S.
    1. U.S. Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. U.S. Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  2. Canada
    1. Canada Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Canada Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  3. Mexico
    1. Mexico Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Mexico Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
Europe Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Europe Point of Care Diagnostics Market, 2016 - 2028 (USD Million)
3. Europe Point of Care Diagnostics Market, by Product
  1. By Glucose Testing
  2. By Hb1Ac Testing
  3. By Coagulation Testing
  4. By Fertility/Pregnancy
  5. By Infectious Disease
  6. By Cardiac Markers
  7. By Thyroid Stimulating Hormone
  8. By Hematology
  9. By Primary Care Systems
  10. By Decentralized Clinical Chemistry
  11. By Feces
  12. By Lipid Testing
  13. By Cancer Marker
  14. By Blood Gas/Electrolytes
  15. By Ambulatory Chemistry
  16. By Drug of Abuse (DOA) Testing
  17. By Urinalysis/Nephrology
4. Europe Point of Care Diagnostics Market, by End Users
  1. By Clinics
  2. By Hospitals
  3. By Home
  4. By Assisted Living Healthcare Facilities
  5. By Laboratories
5. Europe Point of Care Diagnostics Market, by Country
  1. Germany
    1. Germany Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Germany Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  2. UK
    1. UK Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. UK Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  3. France
    1. France Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. France Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  4. Spain
    1. Spain Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Spain Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  5. Italy
    1. Italy Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Italy Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  6. BENELUX
    1. BENELUX Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. BENELUX Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  7. Rest of Europe
    1. Rest Of Europe Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Rest Of Europe Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
Asia Pacific Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Point of Care Diagnostics Market, 2016 - 2028 (USD Million)
3. Asia Pacific Point of Care Diagnostics Market, by Product
  1. By Glucose Testing
  2. By Hb1Ac Testing
  3. By Coagulation Testing
  4. By Fertility/Pregnancy
  5. By Infectious Disease
  6. By Cardiac Markers
  7. By Thyroid Stimulating Hormone
  8. By Hematology
  9. By Primary Care Systems
  10. By Decentralized Clinical Chemistry
  11. By Feces
  12. By Lipid Testing
  13. By Cancer Marker
  14. By Blood Gas/Electrolytes
  15. By Ambulatory Chemistry
  16. By Drug of Abuse (DOA) Testing
  17. By Urinalysis/Nephrology
4. Asia Pacific Point of Care Diagnostics Market, by End Users
  1. By Clinics
  2. By Hospitals
  3. By Home
  4. By Assisted Living Healthcare Facilities
  5. By Laboratories
5. Asia Pacific Point of Care Diagnostics Market, by Country
  1. China
    1. China Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. China Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  2. Japan
    1. Japan Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Japan Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  3. India
    1. India Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. India Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  4. South Korea
    1. South Korea Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. South Korea Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  5. South East Asia
    1. South East Asia Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. South East Asia Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Rest of Asia Pacific Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
Latin America Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Point of Care Diagnostics Market, 2016 - 2028 (USD Million)
3. Latin America Point of Care Diagnostics Market, by Product
  1. By Glucose Testing
  2. By Hb1Ac Testing
  3. By Coagulation Testing
  4. By Fertility/Pregnancy
  5. By Infectious Disease
  6. By Cardiac Markers
  7. By Thyroid Stimulating Hormone
  8. By Hematology
  9. By Primary Care Systems
  10. By Decentralized Clinical Chemistry
  11. By Feces
  12. By Lipid Testing
  13. By Cancer Marker
  14. By Blood Gas/Electrolytes
  15. By Ambulatory Chemistry
  16. By Drug of Abuse (DOA) Testing
  17. By Urinalysis/Nephrology
4. Latin America Point of Care Diagnostics Market, by End Users
  1. By Clinics
  2. By Hospitals
  3. By Home
  4. By Assisted Living Healthcare Facilities
  5. By Laboratories
5. Latin America Point of Care Diagnostics Market, by Country
  1. Brazil
    1. Brazil Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Brazil Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  2. Argentina
    1. Argentina Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Argentina Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  3. Rest of Latin America
    1. Rest of Latin America Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Rest of Latin America Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
Middle East & Africa Point of Care Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Point of Care Diagnostics Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Point of Care Diagnostics Market, by Product
  1. By Glucose Testing
  2. By Hb1Ac Testing
  3. By Coagulation Testing
  4. By Fertility/Pregnancy
  5. By Infectious Disease
  6. By Cardiac Markers
  7. By Thyroid Stimulating Hormone
  8. By Hematology
  9. By Primary Care Systems
  10. By Decentralized Clinical Chemistry
  11. By Feces
  12. By Lipid Testing
  13. By Cancer Marker
  14. By Blood Gas/Electrolytes
  15. By Ambulatory Chemistry
  16. By Drug of Abuse (DOA) Testing
  17. By Urinalysis/Nephrology
4. Middle East & Africa Point of Care Diagnostics Market, by End Users
  1. By Clinics
  2. By Hospitals
  3. By Home
  4. By Assisted Living Healthcare Facilities
  5. By Laboratories
5. Middle East & Africa Point of Care Diagnostics Market, by Country
  1. GCC Countries
    1. GCC Countries Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. GCC Countries Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  2. South Africa
    1. South Africa Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. South Africa Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Point of Care Diagnostics Market, By Product
      1. By Glucose Testing
      2. By Hb1Ac Testing
      3. By Coagulation Testing
      4. By Fertility/Pregnancy
      5. By Infectious Disease
      6. By Cardiac Markers
      7. By Thyroid Stimulating Hormone
      8. By Hematology
      9. By Primary Care Systems
      10. By Decentralized Clinical Chemistry
      11. By Feces
      12. By Lipid Testing
      13. By Cancer Marker
      14. By Blood Gas/Electrolytes
      15. By Ambulatory Chemistry
      16. By Drug of Abuse (DOA) Testing
      17. By Urinalysis/Nephrology
    2. Rest of Middle East & Africa Point of Care Diagnostics Market, By End Users
      1. By Clinics
      2. By Hospitals
      3. By Home
      4. By Assisted Living Healthcare Facilities
      5. By Laboratories
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. F. Hoffmann-La Roche Ltd.
2. Qiagen
3. Danaher Corp.
4. Becton Dickinson (BD)
5. Biomerieux SA
6. Abbott Laboratories
7. Siemens Healthcare AG
8. Zoetis Inc.
9. Instrumentation Laboratory
10. Nova Biomedical
11. Trividia Health Inc.
12. Quidel Corp.
13. Trinity Biotech
14. Sekisui Diagnostics
15. Orasure Technologies Inc.
16. Nipro Corp.
17. Spectral Medical Inc.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 01-Sep-2022

Point of Care Diagnostics Market to Reach Valuation of USD 73.9 Billion By 2028 - Rising Adoption of Decentralized Healthcare Systems to Drive Market Growth

FAQ

Frequently Asked Question

What is the global demand for Point of Care Diagnostics in terms of revenue?

The global Point of Care Diagnostics valued at USD 45.06 Billion in 2022 and is expected to reach USD 95.89 Billion in 2030 growing at a CAGR of 9.90%.

Which are the prominent players in the market?

The prominent players in the market are F. Hoffmann-La Roche Ltd., Qiagen, Danaher Corp., Becton Dickinson (BD), Biomerieux SA, Abbott Laboratories, Siemens Healthcare AG, Zoetis Inc., Instrumentation Laboratory, Nova Biomedical, Trividia Health Inc., Quidel Corp., Trinity Biotech, Sekisui Diagnostics, Orasure Technologies Inc., Nipro Corp., Spectral Medical Inc..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 9.90% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Point of Care Diagnostics include
- High prevalence of infectious diseases

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Point of Care Diagnostics in 2022.

Point of Care Diagnostics Market

Point of Care Diagnostics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Point of Care Diagnostics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Point of Care Diagnostics Market

Point of Care Diagnostics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Point of Care Diagnostics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Point of Care Diagnostics Market

Vantage Point Interactive Dashboard